Premium
Epilepsy treatment gap in Sub‐Saharan Africa: Meta‐analysis of community‐based studies
Author(s) -
Owolabi L. F.,
Owolabi S. D.,
Adamu B.,
Jibo A.M.,
Alhaji I. D.
Publication year - 2020
Publication title -
acta neurologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.967
H-Index - 95
eISSN - 1600-0404
pISSN - 0001-6314
DOI - 10.1111/ane.13246
Subject(s) - medicine , meta analysis , subgroup analysis , demography , medline , epilepsy , psychiatry , sociology , political science , law
Objective To evaluate the prevalence, highlight the variation and determine the trend over time, of epilepsy treatment gap (ETG) in Sub‐Saharan Africa (SSA). Methods We systematically searched PubMed, MEDLINE, Embase, ISI databases, and African Journal Online (AJOL). We determined the pooled prevalence estimate of ETG and the degree of heterogeneity in the region. Further subgroup analysis by sub‐region, settlement setting, and cutoff adopted for active epilepsy in the studies was carried out. Meta‐regression technique was also used to determine the trend of the ETG magnitude over time. Results Twenty‐three studies from SSA met the inclusion criteria. We found a high level of discordance among the studies that were included. Collectively, the estimated ETG was 68.5% (95% CI: 59.5%‐77.5%). On subgroup analysis, the prevalence of the ETG was 67% (95% CI: 52%, 83%) in the Western, 68% (95% CI: 56%, 80%) in the Eastern, and 63% (95% CI: 53%, 73%) in the Southern Africa sub‐regions. On stratified analysis based on 1‐year, 5‐year, and 2‐year cutoffs for definition of active epilepsy, the prevalence figures for the ETG were 71% (95% CI: 56%, 85%), 55% (95% CI: 33%, 77%), and 57% (95% CI: 43%, 71%), respectively. Meta‐regression result suggested that the prevalence of the ETG decreases by approximately by 0.006 per year. Conclusion The study showed a high prevalence of ETG, higher than the average for resource poor countries, and twice in rural compared with urban settlements in SSA.